Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Respiratory Syncytial Virus Disease

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Safety and Immunogenicity of a PD-1-Enhanced HIV-1 Therapeutic DNA Vaccine: A Randomized, Double-Blind, Placebo-Controlled, Dose-Escalating Phase I Clinical Trial in People With HIV-1 on Antiretroviral Therapy.

The Journal of infectious diseases·2026

Same author

Structural basis of cooperative neutralization of the PldB toxin by immunity proteins in Pseudomonas aeruginosa.

Communications biology·2026

Same author

AI-Derived Smart Microneedle Systems for Advanced Wound Management: From Intelligent Sensing to Closed-Loop Therapy.

Macromolecular bioscience·2026

Same author

Psychosocial predictors of chemotherapy-induced nausea and vomiting among chemotherapy-naïve cancer patients: a prospective multicenter cohort study.

Journal of cancer survivorship : research and practice·2026

Same author

Federated Learning via Variational Bayesian Inference: Personalization, Sparsity and Clustering.

IEEE transactions on pattern analysis and machine intelligence·2026

Same author

Integrative Multi-Omics Analysis of Circulating Biomarkers Reveals Targetable Pathways in Pelvic Organ Prolapse.

Current medicinal chemistry·2026

Search research articles

Related Experiment Video

Updated: Jun 28, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

Progress on Respiratory Syncytial Virus Vaccine Development and Evaluation Methods.

Lie Deng¹, Hongjie Cao^1,2, Guichang Li^1,2

¹Guangzhou National Laboratory, Guangzhou 510320, China.

|April 23, 2025

Summary

Developing effective vaccines against Respiratory Syncytial Virus (RSV) is crucial for vulnerable populations. This review details advances in RSV vaccine strategies, immune evaluation, and identifying reliable immunological surrogates for protection.

Keywords:

immunological surrogates respiratory syncytial virus vaccine evaluation vaccines

More Related Videos

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Related Experiment Videos

Last Updated: Jun 28, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection

Published on: December 10, 2013

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

An Improved and High Throughput Respiratory Syncytial Virus RSV Micro-neutralization Assay

Published on: January 26, 2019

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Generation, Amplification, and Titration of Recombinant Respiratory Syncytial Viruses

Published on: April 4, 2019

Area of Science:

Virology
Immunology
Vaccinology

Background:

Respiratory Syncytial Virus (RSV) poses a significant global health risk, particularly to infants, the elderly, and immunocompromised individuals.
Current vaccine development focuses on eliciting robust immune responses against key viral proteins like the fusion (F) protein.

Purpose of the Study:

To review progress in Respiratory Syncytial Virus (RSV) vaccine development.
To examine immune evaluation methods and immunological surrogates for predicting vaccine efficacy.
To discuss challenges and future directions in RSV vaccine research.

Main Methods:

Comprehensive literature review of RSV vaccine research.
Analysis of immunological correlates of protection, including neutralizing antibodies, T cell responses, and B cell memory.
Evaluation of diverse vaccine platforms (live attenuated, subunit, mRNA, nanoparticle).

Main Results:

Prefusion-engineered RSV F protein elicits potent neutralizing antibodies.
Various vaccine platforms show promise, but challenges in safety, immunogenicity, and durability remain.
Neutralizing antibodies, T cell responses, and B cell memory are key immunological surrogates for protection.

Conclusions:

Advances in RSV vaccine development are significant, utilizing novel platforms and immunogens.
Validation of immunological surrogates is critical for assessing vaccine efficacy across diverse populations.
Further research is needed to integrate immunological markers and understand RSV-induced immunity for improved vaccine design.